Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Hyodo

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Nucleic Acid Therapeutics|August 23, 2016
Identification of a Nucleoporin358-Specific RNA Aptamer for Use as a Nucleus-Targeting Liposomal Delivery SystemGarima Shrivastava, Mamoru Hyodo, Shige H Yoshimura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 18, 2012
Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug deliveryMd Nazir Hossen, Kazuaki Kajimoto, Hidetaka Akita, et al.
Biological & Pharmaceutical Bulletin|August 5, 2014
RNA aptamers for targeting mitochondria using a mitochondria-based SELEX methodYuri Tawaraya, Mamoru Hyodo, Mst Naznin Ara, et al.
Plos One|December 11, 2012
Development of a novel DNA aptamer ligand targeting to primary cultured tumor endothelial cells by a cell-based SELEX methodMst Naznin Ara, Mamoru Hyodo, Noritaka Ohga, et al.
Journal of Drug Targeting|May 9, 2014
Comparative assessments of crucial factors for a functional ligand-targeted nanocarrierMd Nazir Hossen, Kazuaki Kajimoto, Ryo Tatsumi, et al.
Journal of Bacteriology|November 4, 2008
The Anaplasma phagocytophilum PleC histidine kinase and PleD diguanylate cyclase two-component system and role of cyclic Di-GMP in host cell infectionTzung-Huei Lai, Yumi Kumagai, Mamoru Hyodo, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
3',5'-cyclic diguanylic acid reduces the virulence of biofilm-forming Staphylococcus aureus strains in a mouse model of mastitis infectionEric Brouillette, Mamoru Hyodo, Yoshihiro Hayakawa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 10, 2013
Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery systemYu Sakurai, Hiroto Hatakeyama, Yusuke Sato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 25, 2012
A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivoYusuke Sato, Hiroto Hatakeyama, Yu Sakurai, et al.
Bioconjugate Chemistry|May 5, 2015
Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting SystemYasuhiro Hayashi, Hiroto Hatakeyama, Kazuaki Kajimoto, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Nucleic Acid Therapeutics|August 23, 2016
Identification of a Nucleoporin358-Specific RNA Aptamer for Use as a Nucleus-Targeting Liposomal Delivery SystemGarima Shrivastava, Mamoru Hyodo, Shige H Yoshimura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 18, 2012
Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug deliveryMd Nazir Hossen, Kazuaki Kajimoto, Hidetaka Akita, et al.
Biological & Pharmaceutical Bulletin|August 5, 2014
RNA aptamers for targeting mitochondria using a mitochondria-based SELEX methodYuri Tawaraya, Mamoru Hyodo, Mst Naznin Ara, et al.
Plos One|December 11, 2012
Development of a novel DNA aptamer ligand targeting to primary cultured tumor endothelial cells by a cell-based SELEX methodMst Naznin Ara, Mamoru Hyodo, Noritaka Ohga, et al.
Journal of Drug Targeting|May 9, 2014
Comparative assessments of crucial factors for a functional ligand-targeted nanocarrierMd Nazir Hossen, Kazuaki Kajimoto, Ryo Tatsumi, et al.
Journal of Bacteriology|November 4, 2008
The Anaplasma phagocytophilum PleC histidine kinase and PleD diguanylate cyclase two-component system and role of cyclic Di-GMP in host cell infectionTzung-Huei Lai, Yumi Kumagai, Mamoru Hyodo, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
3',5'-cyclic diguanylic acid reduces the virulence of biofilm-forming Staphylococcus aureus strains in a mouse model of mastitis infectionEric Brouillette, Mamoru Hyodo, Yoshihiro Hayakawa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 10, 2013
Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery systemYu Sakurai, Hiroto Hatakeyama, Yusuke Sato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 25, 2012
A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivoYusuke Sato, Hiroto Hatakeyama, Yu Sakurai, et al.
Bioconjugate Chemistry|May 5, 2015
Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting SystemYasuhiro Hayashi, Hiroto Hatakeyama, Kazuaki Kajimoto, et al.
Pageof 8